Pharmaceuticals for neurogenic pain
AssigneeYamanouchi Pharmaceutical Co., Ltd.
InventorsMasamichi Okada, Yukinori Nagakura, Tetsuo Kiso, Takashi Toya, Satoshi Hayashibe
Life of this patent
Estimating the term…
Abstract
This invention relates to pharmaceuticals for neuropathic pains comprising an mGluR1 receptor antagonist for systemic administration. Drugs efficacious in treating various neuropathic pain can be provided by the invention.
Claims4
A pharmaceutical composition for use in treating neuropathic pain, which is administered by a systemic method of administration and which comprises a compound having mGluR1 antagonistic activity, wherein the compound having mGluR1 antagonism is a compound selected from 6-amino-N-cyclohexyl-N, 3-dimethylthiazolo[3,2-a]benzoimidazole-2-carboxamide dihydrochloride and (+)-(1R,2S)-6-amino-N-methyl-N-(2-methylcyclohexyl)thiazolo[3,2-a]benzoimidazole-2-carboxamide dihydrochloride.
Dependencies are inferred from the claim text.